| Gregory F Kozielec, MD | |
|
3414 Oak Grove Ave, Dallas, TX 75204-2375 | |
| (214) 521-1153 | |
| (214) 219-3651 |
| Full Name | Gregory F Kozielec |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 30 Years |
| Location | 3414 Oak Grove Ave, Dallas, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053379081 | NPI | - | NPPES |
| 044052103 | Medicaid | TX | |
| 8583K0 | Other | TX | BCBS/GRP 00T587 |
| 044052101 | Medicaid | TX | |
| 044052102 | Medicaid | TX | |
| 168274001 | Medicaid | AR | |
| 180043890 | Other | TX | RR MEDICARE GRP CJ5857 |
| 7909137 | Other | TX | AETNA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor Surgical Hospital At Las Colinas | Irving, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Retina Institute Of Texas Pa | 9234160581 | 4 |
News Archive
The Obesity Society (TOS) and the Obesity Action Coalition (OAC) today called on the Food and Drug Administration (FDA) to consider the urgent need for more tools to address the obesity epidemic facing more than 93 million Americans as they convene an advisory panel to review a new treatment for obesity.
NIBIB-supported researchers have created tiny gel particles that can perform the same essential functions as platelets. The particles could one day be used to control excessive bleeding following traumatic injury or in individuals with impaired clotting due to an inherited condition or as a result of certain medications or chemotherapy.
The New research published in The Journal of Physiology has shown that ketone supplements may be a novel therapeutic strategy for protecting and improving brain health in people with obesity.
New guidelines issued by the American Gastroenterological Association (AGA) support the use of radiofrequency ablation (RFA) to remove precancerous cells in patients with Barrett's esophagus, a condition most commonly caused by chronic acid reflux, or GERD. Barrett's esophagus is the leading cause of esophageal cancer and affects an estimated two million Americans.
› Verified 5 days ago
| Entity Name | Retina Institute Of Texas Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326097460 PECOS PAC ID: 9234160581 Enrollment ID: O20050825001011 |
News Archive
The Obesity Society (TOS) and the Obesity Action Coalition (OAC) today called on the Food and Drug Administration (FDA) to consider the urgent need for more tools to address the obesity epidemic facing more than 93 million Americans as they convene an advisory panel to review a new treatment for obesity.
NIBIB-supported researchers have created tiny gel particles that can perform the same essential functions as platelets. The particles could one day be used to control excessive bleeding following traumatic injury or in individuals with impaired clotting due to an inherited condition or as a result of certain medications or chemotherapy.
The New research published in The Journal of Physiology has shown that ketone supplements may be a novel therapeutic strategy for protecting and improving brain health in people with obesity.
New guidelines issued by the American Gastroenterological Association (AGA) support the use of radiofrequency ablation (RFA) to remove precancerous cells in patients with Barrett's esophagus, a condition most commonly caused by chronic acid reflux, or GERD. Barrett's esophagus is the leading cause of esophageal cancer and affects an estimated two million Americans.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory F Kozielec, MD 3414 Oak Grove Ave, Dallas, TX 75204-2375 Ph: (214) 521-1153 | Gregory F Kozielec, MD 3414 Oak Grove Ave, Dallas, TX 75204-2375 Ph: (214) 521-1153 |
News Archive
The Obesity Society (TOS) and the Obesity Action Coalition (OAC) today called on the Food and Drug Administration (FDA) to consider the urgent need for more tools to address the obesity epidemic facing more than 93 million Americans as they convene an advisory panel to review a new treatment for obesity.
NIBIB-supported researchers have created tiny gel particles that can perform the same essential functions as platelets. The particles could one day be used to control excessive bleeding following traumatic injury or in individuals with impaired clotting due to an inherited condition or as a result of certain medications or chemotherapy.
The New research published in The Journal of Physiology has shown that ketone supplements may be a novel therapeutic strategy for protecting and improving brain health in people with obesity.
New guidelines issued by the American Gastroenterological Association (AGA) support the use of radiofrequency ablation (RFA) to remove precancerous cells in patients with Barrett's esophagus, a condition most commonly caused by chronic acid reflux, or GERD. Barrett's esophagus is the leading cause of esophageal cancer and affects an estimated two million Americans.
› Verified 5 days ago
Dr. Joanna Saade, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-2020 | |
Dr. Julie Linden Soto, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1703 N Beckley Ave, Dallas, TX 75203 Phone: 214-987-2875 Fax: 214-946-9877 | |
Miss Vanessa Ortiz-medina, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-2020 | |
Dr. Deborah I Friedman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Boulevard, Dallas, TX 75390 Phone: 214-645-0624 Fax: 214-645-0078 | |
Faisal E Haq, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2801 Lemmon Ave Ste 400, Dallas, TX 75204 Phone: 214-754-0000 Fax: 214-379-1849 | |
Gary Pesicka, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-2020 | |
Phillip Alan Tenzel, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75284 Phone: 214-645-2020 |